Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    evonik-m-2025-09-08

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Menu

    Alendronic Acid Monohydrate

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 102Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 9Fosamax

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Organon

    Alendronic Acid

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2021 Revenue in Millions : 175

    2020 Revenue in Millions : 180

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Organon

    Alendronic Acid

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2022 Revenue in Millions : 152

    2021 Revenue in Millions : 175

    Growth (%) : -13

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Organon

    Alendronic Acid

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2023 Revenue in Millions : 159

    2022 Revenue in Millions : 152

    Growth (%) : 5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Organon

    Alendronic Acid

    Main Therapeutic Indication : Musculoskeletal

    Currency : USD

    2024 Revenue in Millions : 151

    2023 Revenue in Millions : 159

    Growth (%) : -5

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Merck & Co

    Alendronic Acid

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2015 Revenue in Millions : 470

    2014 Revenue in Millions : 359

    Growth (%) : -24%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Merck & Co

    Alendronic Acid

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2014 Revenue in Millions : -16.10%

    2013 Revenue in Millions :

    Growth (%) :

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Merck & Co.

    Alendronic Acid

    Main Therapeutic Indication : Bone Health

    Currency : USD

    2016 Revenue in Millions : 284

    2015 Revenue in Millions : 359

    Growth (%) : -21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Merck & Co. Inc.

    Alendronic Acid

    Main Therapeutic Indication : Bone and Joint Diseases

    Currency : USD

    2017 Revenue in Millions : 241

    2016 Revenue in Millions : 284

    Growth (%) : -15

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Fosamax

    Alendronic Acid

    arrow
    ESCRS
    Not Confirmed

    Brand Name : Fosamax

    U.S.A
    arrow
    ESCRS
    Not Confirmed

    Merck & Co.

    Alendronic Acid

    Main Therapeutic Indication : Bone And Joint Diseases

    Currency : USD

    2018 Revenue in Millions : 209

    2017 Revenue in Millions : 241

    Growth (%) : -13%

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF